Conference Coverage: ASCO 2022 – Focus on Genitourinary (GU)
Impact of recent ASCO data on clinical practice and therapy guidance in genitourinary cancer
FACULTY MEMBERS
Emmanuel Antonarakis, MD
University of Minnesota Medical School, Minneapolis, MN, USA
Joaquim Bellmunt, MD, PhD
Harvard Medical School, Boston, MA, USA
Robert Dreicer, MD, MS, MACP, FASCO
University of Virginia Cancer Center, Charlottesville, VA, USA
Karim Fizazi, MD, PhD
Institute Gustave Roussy, Villejuif, France
Leonard G. Gomella, MD, FACS
Jefferson University Hospitals, Philadelphia, PA, USA
Thomas Powles, MD, MBBS, MRCP
Barts Cancer Institute, London, UK
Susan Slovin, MD, PhD, FACP
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Scott Tagawa, MD, MS, FACP
Weill Cornell Medical Center, New York, NY, USA
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Localized and Metastatic Castration-Sensitive Prostate Cancer
- Metastatic Castration-Resistant Prostate Cancer
- Advanced Renal Cell Carcinoma
- Renal Cell Carcinoma – Subgroup-Specific Therapies
- Novel Therapies for NMIBC and MIBC
- Novel Therapies for Metastatic Bladder Cancers
